Rentokil Initial Plc Stock Performance
RKLIF Stock | USD 4.69 0.67 16.67% |
On a scale of 0 to 100, Rentokil Initial holds a performance score of 5. The company holds a Beta of 0.58, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Rentokil Initial's returns are expected to increase less than the market. However, during the bear market, the loss of holding Rentokil Initial is expected to be smaller as well. Please check Rentokil Initial's semi variance, and the relationship between the maximum drawdown and daily balance of power , to make a quick decision on whether Rentokil Initial's historical price patterns will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Rentokil Initial plc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain forward indicators, Rentokil Initial reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow | 550.8 M | |
Total Cashflows From Investing Activities | -441.1 M |
Rentokil |
Rentokil Initial Relative Risk vs. Return Landscape
If you would invest 430.00 in Rentokil Initial plc on December 24, 2024 and sell it today you would earn a total of 39.00 from holding Rentokil Initial plc or generate 9.07% return on investment over 90 days. Rentokil Initial plc is currently producing 0.214% returns and takes up 2.9424% volatility of returns over 90 trading days. Put another way, 26% of traded pink sheets are less volatile than Rentokil, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Rentokil Initial Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rentokil Initial's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Rentokil Initial plc, and traders can use it to determine the average amount a Rentokil Initial's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0727
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | RKLIF | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.94 actual daily | 26 74% of assets are more volatile |
Expected Return
0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Rentokil Initial is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rentokil Initial by adding it to a well-diversified portfolio.
Rentokil Initial Fundamentals Growth
Rentokil Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Rentokil Initial, and Rentokil Initial fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Rentokil Pink Sheet performance.
Return On Equity | 0.21 | |||
Return On Asset | 0.0419 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.13 % | |||
Current Valuation | 18.1 B | |||
Shares Outstanding | 2.52 B | |||
Price To Earning | 38.36 X | |||
Price To Book | 9.36 X | |||
Price To Sales | 5.35 X | |||
Revenue | 2.96 B | |||
EBITDA | 656.6 M | |||
Cash And Equivalents | 2.37 B | |||
Cash Per Share | 1.28 X | |||
Total Debt | 1.26 B | |||
Debt To Equity | 2.64 % | |||
Book Value Per Share | 0.77 X | |||
Cash Flow From Operations | 563.2 M | |||
Earnings Per Share | 0.17 X | |||
Total Asset | 4.32 B | |||
Retained Earnings | 2.07 B | |||
Current Asset | 593 M | |||
Current Liabilities | 789 M | |||
About Rentokil Initial Performance
By analyzing Rentokil Initial's fundamental ratios, stakeholders can gain valuable insights into Rentokil Initial's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Rentokil Initial has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Rentokil Initial has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom. Rentokil Initial operates under Specialty Business Services classification in the United States and is traded on OTC Exchange. It employs 46000 people.Things to note about Rentokil Initial plc performance evaluation
Checking the ongoing alerts about Rentokil Initial for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Rentokil Initial plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Over 76.0% of the company shares are owned by institutional investors |
- Analyzing Rentokil Initial's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Rentokil Initial's stock is overvalued or undervalued compared to its peers.
- Examining Rentokil Initial's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Rentokil Initial's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Rentokil Initial's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Rentokil Initial's pink sheet. These opinions can provide insight into Rentokil Initial's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Rentokil Pink Sheet analysis
When running Rentokil Initial's price analysis, check to measure Rentokil Initial's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rentokil Initial is operating at the current time. Most of Rentokil Initial's value examination focuses on studying past and present price action to predict the probability of Rentokil Initial's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rentokil Initial's price. Additionally, you may evaluate how the addition of Rentokil Initial to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |